Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product ...

Looking for the most shorted stocks?

Guns N’ Roses came at exactly the right time in rock ‘n’ roll. For the better part of the ‘80s, rock music had become bloated, stagnate and full of itself. Still reeling from the disco and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The results presented at ESCMID further support the favorable safety profile for bemnifosbuvir by demonstrating the lack of cardiotoxicity in healthy participants,” said Jean-Pierre Sommadossi, PhD, ...

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Atea Pharmaceuticals (ticker: AVIR), in its Q4 2023 earnings call, detailed the advancements in its antiviral drug programs, including its COVID-19 and hepatitis C virus (HCV) ...